ampicillin has been researched along with bromopyruvate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chigan, JZ; Ding, HH; Gao, H; Li, JQ; Sun, LY; Yang, KW; Zhai, L | 1 |
| Shi, J; Tong, R; Wang, T; Xiong, L; Xu, K; Zhao, L | 1 |
1 review(s) available for ampicillin and bromopyruvate
| Article | Year |
|---|---|
Recent research and development of NDM-1 inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Catalytic Domain; Drug Resistance, Bacterial; Molecular Docking Simulation; Picolinic Acids; Sulfonamides | 2021 |
1 other study(ies) available for ampicillin and bromopyruvate
| Article | Year |
|---|---|
Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiosemicarbazones | 2021 |